Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Distal renal tubular acidosis in Sjögren syndrome and postmenopausal osteoporosis
NL-OMON36946Withdrawn
- Sponsor
- Erasmus MC
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ammonium chloride, furosemide and fludrocortisone in renal tubular acidosis (RTA) (2 cohorts), sponsored by Erasmus MC. Primary endpoints: Prevalence of distal renal tubular acidosis in primary Sjögren syndrome, Prevalence of calcium metabolism disorders in primary Sjögren syndrome with distal renal tubular acidosis and 4 more. Planned start Dec 2012; status: withdrawn.
02
Drugs
03
Conditions
renal tubular acidosis (RTA)
Beyond the preview
Go deeper on NL-OMON36946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36946.